FDA Alert: Invirase (saquinavir): Label Change - Risk of Abnormal Heart Rhythm
Links shared publicly online about this topic.
- 785total visits
FDA Alert: Invirase (saquinavir): Label Change - Risk of Abnormal Heart Rhythm
View full resource at drugs.com
Tags: Heart, HIV Medication, FDA, Invirase
Most Recently Shared on October 21, 2010 at 8:52 pm By:
FDA Alert - Labeling Change for Invirase (saquinavir) - Risk of Abnormal Heart Rhythm - http://bit.ly/9nxaPY
Advertisement

